Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)

The National Center for Advancing Translational Science (NCATS) is seeking to support research on extracellular vesicles (EVs) and their use as therapeutics in regenerative medicine. The main objective of this program, Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe), is to advance the translation of EV-based therapeutics in regenerative medicine. Areas of interest for ExTReMe could include, but are not limited to: • Direct EV therapy (stem cell-isolated EVs produced under GLP conditions, and stored as off-the-shelf therapies) • Designer EVs (personalized to the individual patient’s needs) The grant will support research in these areas, with the goal of advancing the field of regenerative medicine.